Investment
- Retainer (Coordination + Marketing): $18,000
- Ad Spend: $5,561
- Total Marketing Investment: $23,561
Funnel Performance (So Far)
| Metric | Value |
| Total Leads | 964 |
| Evals Scheduled | 53 |
| Evals Showed | 22 |
| Patients Converted | 10 |
| LTV per Patient | $7,500 |
Pipeline Still Active
- 2 pending treatments likely to be approved
- 4 upcoming evaluations already scheduled
- Additional active leads still moving through coordination
Based on historical conversion rates, we conservatively estimate +3 additional patients.
Cost Metrics (Ads Only)
- CPL: $5.77
- CPE (Scheduled): $104.93
- CPE (Showed): $252.77
- CPP (Current): $556.10
Projected CPP (With 3 More Patients)
- $5,561 ÷ 13 patients = $427.77 per patient
Conversion Rates
- Lead → Eval Scheduled: 5.49%
- Eval Scheduled → Showed: 41.5%
- Eval Showed → Patient: 45.45%
- Lead → Patient (Current): 1.04%
Revenue & Profitability
Revenue Generated (Current)
- 10 patients × $7,500 = $75,000
Projected Revenue Increase
- +3 patients × $7,500 = +$22,500
Total Projected Revenue
- $97,500
ROAS & ROI
ROAS (Ad Spend Only – Projected)
- $97,500 ÷ $5,561 = 17.54× ROAS
(1,754% return on ad spend)
ROI (All-In: Retainer + Ads – Projected)
- Net Profit: $97,500 − $23,561 = $73,939
- ROI: 314%
Summary
From September to December, Kite delivered:
- 964 leads
- 53 evaluations scheduled
- 22 evaluations showed
- 10 patients converted (with +3 more projected)
- $97,500 projected revenue
- 17.54× ROAS (ads only)
- 314% ROI (all-in investment)
With pending approvals, upcoming evaluations, and an active lead pipeline, performance is still compounding beyond the initial results.
